Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

180,732 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Clinical analysis of the therapeutic effect of allogeneic hematopoietic stem cell transplantation in 10 cases of childhood myelodysplastic syndrome/myeloproliferative neoplasm].
Sun YN, Hu SY, He HL, Wang Y, Li J, Lu J, Xiao PF, Yao YH, Fan JJ, Lyu H, Ling J, Hu DX, Wu DP. Sun YN, et al. Among authors: li j. Zhonghua Xue Ye Xue Za Zhi. 2018 Feb 14;39(2):162-164. doi: 10.3760/cma.j.issn.0253-2727.2018.02.018. Zhonghua Xue Ye Xue Za Zhi. 2018. PMID: 29562455 Free PMC article. Chinese. No abstract available.
[Long-term follow-up of multiple myeloma after autologous hematopoietic stem cell transplantation: a single center results].
Sui WW, Zou DH, An G, Yi SH, Deng SH, Huang WY, Wang TY, Li J, Liu H, Fu MW, Lyu R, Liu W, Xu Y, Li ZJ, Zhao YZ, Qiu LG. Sui WW, et al. Among authors: li zj, li j. Zhonghua Xue Ye Xue Za Zhi. 2017 Jun 14;38(6):499-504. doi: 10.3760/cma.j.issn.0253-2727.2017.06.007. Zhonghua Xue Ye Xue Za Zhi. 2017. PMID: 28655093 Free PMC article. Chinese.
[Prognostic factors in newly diagnosed multiple myeloma patients with 1q21 amplification/gain treated with bortezomib-based regimens followed by autologous hematopoietic stem cell transplantation].
Huang WY, Zou DH, Liu W, An G, Xu Y, Sui WW, Deng SH, Li CW, Liu H, Li J, Qiu LG. Huang WY, et al. Among authors: li cw, li j. Zhonghua Xue Ye Xue Za Zhi. 2018 Jun 14;39(6):496-500. doi: 10.3760/cma.j.issn.0253-2727.2018.06.012. Zhonghua Xue Ye Xue Za Zhi. 2018. PMID: 30032568 Free PMC article. Chinese.
[Lenalidomide, rituximab and dexamethasone for the treatment of recurrent/refractory or elderly newly diagnosed patients with primary central nervous system lymphoma: 5 cases report and literature review].
Bai JF, Feng R, Han HX, Wang T, Li JT, Zhang CL, Liu H. Bai JF, et al. Among authors: li jt. Zhonghua Xue Ye Xue Za Zhi. 2019 Dec 14;40(12):1047-1049. doi: 10.3760/cma.j.issn.0253-2727.2019.12.016. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 32023740 Free PMC article. Chinese. No abstract available.
[Dose-enhanced immunochemotherapy followed by first-line autologous peripheral blood stem cell transplantation for young patients with high-risk aggressive B-cell lymphoma: an efficacy and prognostic factor analysis].
Wang Y, Liu W, Huang WY, Lyu R, Li J, Deng SH, Sui WW, Liu H, Wang TY, Yi SH, Liu HM, Qiu LG, Zou DH. Wang Y, et al. Among authors: li j. Zhonghua Xue Ye Xue Za Zhi. 2022 Mar 14;43(3):215-220. doi: 10.3760/cma.j.issn.0253-2727.2022.03.006. Zhonghua Xue Ye Xue Za Zhi. 2022. PMID: 35405779 Free PMC article. Chinese.
180,732 results
You have reached the last available page of results. Please see the User Guide for more information.